Insulet corporationPODD.US Overview

US StockHealthcare

(No presentation for PODD)

Overview AI Analysis AI Earnings Summary Financials Financial Forecast Stock Sentimental Institutions TradingView Chart

PODD Overall Performance

PODD AI Analysis & Strategy

PODD Recent Performance

3.81%

Insulet corporation

0.81%

Avg of Sector

-1.14%

S&P500

PODD PowerScanner

PODD Key Information

PODD Valuation Metrics

PODD Earnings Table

PODD Profile

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.